[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100558393":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":33,"collaborators":7,"id":35,"slug":7,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":39,"acronym":40,"eligibilityCriteria":41,"healthyVolunteers":36,"sex":42,"minAge":43,"maxAge":44,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"University Hospital, Brest","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Sarah BOUEE","CONTACT","02 98 22 39 70","sarah.bouee@chu-brest.fr",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"Anne-Solenn JACAMON","anne-solenn.jacamon@chu-brest.fr",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"CHRU de Brest","RECRUITING","Brest","29609","France","FR",{"type":26,"coordinates":27},"Point",[28,29],-4.48628,48.39029,{"lat":29,"lon":28},[32],{"name":10,"role":11,"phone":7,"phoneExt":7,"email":13},{"type":34,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100558393",false,"NCT06550531","Impact of Human Papillomavirus Carriage on IVF\u002FICSI Results (HPV AMP)","Impact of Human Papillomavirus Carriage on IVF\u002FICSI Results at Brest University Hospital","HPV-AMP","Inclusion Criteria:\n\n* all etiology of infertility AMH \\> ou = à 1.1 ng\u002Fml First ou second protocol of IVF between 25 years and 37 years and 11 months\n\nExclusion Criteria:\n\nAge \\\u003C 25 y Age \\> ou = 38 y AMH \\\u003C 1.1 ng\u002Fml patient under juridic protection rejection of participation","FEMALE","25 Years","38 Years",{"count":46,"type":47},618,"ESTIMATED","OBSERVATIONAL","The prevalence of the papilloma virus in the general population is 12%. This virus is known to impair male fertility but its impact on female infertility remains uncertain. This is a public health problem since there is a vaccination protocol. Demonstrating the impact of the human papillomavirus on fertility would be an argument in favor of vaccination.",[51,52],"Human Papilloma Virus","Infertility, Female","2024-08-09",{"date":55,"type":56},"2024-08-13","ACTUAL",{"date":58,"type":56},"2022-02-04",{"date":60,"type":47},"2026-02-04",{"name":5,"class":6},1]